According to GlobalData’s medical device pipeline database, 216 Bone Grafts and Substitutes devices are in various stages of development globally. GlobalData’s report Bone Grafts and Substitutes provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 88 are in active development, while the remaining 128 are in an inactive stage of development. There are 38 products in the early stages of development, and the remaining 50 are in the late stages of development.

Bone Grafts and Substitutes are used in surgical procedures of bones in the human body under two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to number of factors such as age and degenerative diseases. Bone graft substitutes are synthetic substances which are an alternative to bone allografts and autografts. Allograft Bone Chips, Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), synthetic bone substitutes, and cell-based matrices are covered under this segment. The applications in the segment are based on the division of entire skeleton structure into Trauma for fractures;-CMF for cranio maxillofacial (excluding the dental market which is covered within a different market); spinal fusions (since all spinal fusions will need some amount of bone graft usage), and joint reconstruction and replacements (including repairs) for large joints which includes hip and knee, and other joints which include shoulder, elbow, wrist, digit and ankle.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Bone Grafts and Substitutes pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Bone Grafts and Substitutes devices. Overall, most of these Bone Grafts and Substitutes pipeline devices are being developed by private entities.

Key players involved in the active development of Bone Grafts and Substitutes include BoneSupport, Bonus BioGroup, Graftys, Wright Medical Group, Medtronic, ROKIT Healthcare, Kuros Biosciences, Bone Solutions, Bone Biologics and Bio2 Technologies.

For a complete picture of the developmental pipeline for Bone Grafts and Substitutes devices, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.